Paper280147
Relative potencies of anti-herpes compounds.
Collins P and 1 other. Ann N Y Acad Sci, 1977. Cited by 59 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Relative potencies of anti-herpes compounds. Papers, record 280147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/280147
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Herpesviridae | Major topic |
| Microbial Sensitivity Tests | |
| Viral Plaque Assay | |
| Virus Cultivation |
Source PubMed
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28,883,376 | In vitro Evaluation of Acyclovir/Chitosan Floating Systems. | Materials (Basel) | 2010 | https://conductscience.org/library/papers/28883376 | PubMed |
| 9,420,039 | Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet. | Antimicrob Agents Chemother | 1997 | https://conductscience.org/library/papers/9420039 | PubMed |
| 7,192,534 | Inhibition of cellular alpha and virally induced deoxyribonucleic acid polymerases by the triphosphate of acyclovir. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/7192534 | PubMed |
| 6,324,666 | Inhibition of cellular alpha DNA polymerase and herpes simplex virus-induced DNA polymerases by the triphosphate of BW759U. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6324666 | PubMed |
| 6,284,470 | Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections. | Drugs | 1982 | https://conductscience.org/library/papers/6284470 | PubMed |
| 6,275,127 | Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities. | J Virol | 1981 | https://conductscience.org/library/papers/6275127 | PubMed |
| 6,272,627 | Activity of trifluorothymidine against cytomegalovirus. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/6272627 | PubMed |
| 6,264,131 | Phosphorylation of acyclovir [9-(2-hydroxyethoxymethyl)guanine] in Epstein-Barr virus-infected lymphoblastoid cell lines. | J Virol | 1981 | https://conductscience.org/library/papers/6264131 | PubMed |
| 6,254,061 | Acyclovir inhibition of Epstein-Barr virus replication. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6254061 | PubMed |
| 6,182,836 | Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6182836 | PubMed |
| 3,631,945 | Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3631945 | PubMed |
| 3,010,836 | Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/3010836 | PubMed |
| 2,987,969 | Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibition. | Proc Natl Acad Sci U S A | 1985 | https://conductscience.org/library/papers/2987969 | PubMed |
| 2,817,855 | Activities of two new antiviral agents against guinea pig lymphotropic herpesvirus infection in vitro. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2817855 | PubMed |
| 2,544,857 | The stereoselective enzymatic synthesis of 9-beta-D-2'-deoxyribofuranosyl 1-deazapurine. | Nucleic Acids Res | 1989 | https://conductscience.org/library/papers/2544857 | PubMed |
| 2,536,930 | 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovir. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2536930 | PubMed |
| 1,765,135 | Antimicrobial and antiviral activity of xylosyl-methylthio-adenosine, a naturally occurring analogue of methylthio-adenosine from Doris verrucosa. | Experientia | 1991 | https://conductscience.org/library/papers/1765135 | PubMed |
| 232,189 | Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate. | J Virol | 1979 | https://conductscience.org/library/papers/232189 | PubMed |
| 202,961 | Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/202961 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/280147
GET https://conductscience.org/api/papers/v1/280147/authors